Development of reversible and irreversible inhibitors of Na+/Ca2+ exchange in pituitary plasma membrane vesicles.
D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D066298:In Vitro Techniques; D008954:Models, Biological; D010902:Pituitary Gland / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*; D013329:Structure-Activity Relationship
C013407:benzamil; D000584:Amiloride; D012964:Sodium; D002118:Calcium